Informed Consent
Item
Signed written informed consent.
boolean
C0021430 (UMLS CUI [1])
Gender; Age
Item
Females or males age ≥ 18 years old.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
ECOG performance status
Item
Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.
text
C1520224 (UMLS CUI [1])
Life Expectancy
Item
Life expectancy of at least 12 weeks.
boolean
C0023671 (UMLS CUI [1])
Carcinoma breast stage IV
Item
Subjects must have histologically or cytologically confirmed invasive breast cancer, with Stage IV disease.
boolean
C0278488 (UMLS CUI [1])
HER2-positive carcinoma of breast
Item
ErbB2 overexpressing breast cancer, defined as 3+ staining by immunohistochemistry (IHC), or 2+ staining by IHC in conjunction with ErbB2 gene amplification by FISH, or ErbB2 gene amplification by FISH alone (in subjects whose tumor blocks were not assessed by IHC). ErbB2 gene amplification is defined by: > 6 ErbB2 gene copies/nucleus for test systems without an internal control probe or an ErbB2/CEP 17 ratio of more than 2.2. Subjects with tumors that are 2+ by IHC but negative or borderline by FISH assay are ineligible. For subjects with a history of more than one primary breast cancer, each breast cancer must be ErbB2 overexpressing to be eligible.
boolean
C1960398 (UMLS CUI [1])
Lesion of brain, Measurable
Item
At least one measurable lesion in the brain, defined as any lesion >=10 mm in longest dimension on T1-weighted, gadolinium-enhanced MRI. Measurable brain lesions should not have been treated with prior stereotactic radiosurgery (SRS); an exception being a brain lesion whose longest linear dimension increased ≥ 50% following SRS and whose absolute longest dimension now measures >= 15mm.
boolean
C0221505 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain, Whole brain radiation therapy, Stereotactic surgery
Item
Prior treatment of brain metastases with WBRT and/or SRS.
boolean
C0220650 (UMLS CUI [1,1])
C1520143 (UMLS CUI [1,2])
C1735594 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain, New; Metastatic malignant neoplasm to brain, Progressive Disease
Item
Unequivocal evidence of new and / or progressive lesions in the brain on an imaging study; Note: Subjects with progressive brain lesions are not required to meet RECIST criteria for CNS progression in order to be eligible for this study.
boolean
C0220650 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
C0220650 (UMLS CUI [2,1])
C1335499 (UMLS CUI [2,2])
Therapeutic procedure, Trastuzumab, Previous
Item
Prior treatment with trastuzumab, either alone or in combination with chemotherapy is required. Trastuzumab will be discontinued at least 2 weeks prior to enrollment on study.
boolean
C0087111 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
Cardiac ejection fraction
Item
Cardiac ejection fraction within institutional range of normal as measured by echocardiogram. Subjects who require cardiac medications (e.g. positive inotropic agents or afterload reducers) for normal ejection fraction are ineligible. MUGA scans will be accepted in cases where an echocardiogram cannot be performed or is inconclusive.
boolean
C0232174 (UMLS CUI [1])
Prior Radiation Therapy; Prior Chemotherapy; Prior Immunotherapy; Biological treatment, Prior Therapy; Hormone Therapy, Prior Therapy
Item
At least 2 weeks since prior radiotherapy, last chemotherapy, immunotherapy, biologic therapy, or hormonal therapy for cancer, and sufficiently recovered or stabilized from side effects associated with prior therapy. Concurrent treatment with bisphosphonates is permitted.
boolean
C0279134 (UMLS CUI [1])
C1514457 (UMLS CUI [2])
C1514461 (UMLS CUI [3])
C1531518 (UMLS CUI [4,1])
C1514463 (UMLS CUI [4,2])
C0279025 (UMLS CUI [5,1])
C1514463 (UMLS CUI [5,2])
Operative Surgical Procedures; Major
Item
At least 3 weeks since major surgical procedures.
boolean
C0543467 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Able to swallow, Oral Medication; Oral Medication, Ability, Retained
Item
Able to swallow and retain oral medications.
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
C0175795 (UMLS CUI [2,1])
C0085732 (UMLS CUI [2,2])
C0333118 (UMLS CUI [2,3])
Childbearing Potential, Pregnancy test negative, Contraceptive methods
Item
Women of childbearing potential must have a negative serum pregnancy test at screening and must use an approved contraceptive method, if appropriate (for example, intrauterine device [IUD], birth control pills, or barrier device) beginning 2 weeks before the first dose of investigational product and for 28 days after the final dose of investigational product. Males able to father a child must practice adequate methods of birth control or practice complete abstinence from intercourse from the first dose of investigational treatment until one week after the final dose of investigational treatment.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
Screening procedure, Complete
Item
Subjects must complete all screening assessments as outlined in the protocol.
boolean
C0220908 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
body system or organ function, physiological aspects; Bone Marrow, physiological aspects
Item
Subjects must have normal organ and marrow function as defined below: SYSTEM LABORATORY VALUES Hematologic: - ANC (absolute neutrophil count) ≥ 1.5 x 109/L - Hemoglobin ≥ 10 g/dL (after transfusion if needed) - Platelets ≥ 100 x 109/L Hepatic: - Albumin ≥ 2.5 g/dL - Serum bilirubin ≤ 1.5x ULN unless due to Gilbert’s syndrome - AST and ALT ≤ 5x ULN if documented liver metastases / ≤ 3x ULN without liver metastases Renal: - Serum Creatinine ≤ 1.2 mg/dL or - Calculated Creatinine Clearance1 ≥ 50 mL/min 1. Calculated by the Cockcroft and Gault Method refer to Section 13.5, Appendix 5
boolean
C0678852 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Prior Chemotherapy, Prior Radiation Therapy, Prior Therapy, Toxic effect
Item
Subjects who have had chemotherapy or radiotherapy within 2 weeks prior to entering the study or who have unresolved or unstable, serious toxicity from prior administration of another investigational drug and/or of prior cancer treatment.
boolean
C0279134 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C0600688 (UMLS CUI [2,2])
Study Subject Participation Status
Item
Concurrent treatment with an investigational agent or participation in another treatment clinical trial.
boolean
C2348568 (UMLS CUI [1])
Topoisomerase I Inhibitors, Prior Therapy
Item
Prior therapy with a topoisomerase 1 inhibitor.
boolean
C0594374 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Lapatinib, Prior Therapy
Item
Prior lapatinib therapy.
boolean
C1506770 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Capecitabine, Prior Therapy
Item
Prior therapy with capecitabine.
boolean
C0671970 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
Dihydropyrimidine Dehydrogenase Deficiency
Item
Known dihydropyrimidine dehydrogenase (DPD) deficiency.
boolean
C1959620 (UMLS CUI [1])
ECOG performance status
Item
ECOG Performance Status 2 or greater.
boolean
C1520224 (UMLS CUI [1])
Chemotherapy Regimen, Concurrent; Therapeutic radiology procedure, Concurrent; Immunotherapy, Concurrent; Biological treatment, Concurrent; Hormone Therapy, Concurrent
Item
Subjects receiving concurrent chemotherapy, radiation therapy, immunotherapy, biologic therapy (including an ErbB1 and/or ErbB2 inhibitor), or hormonal therapy for treatment of their cancer. Hormone therapy for ovarian suppression which has been used for > 6 months, during which time there has been disease progression in the brain, is allowed. Concurrent treatment with bisphosphonates is allowed.
boolean
C0392920 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0205420 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0205420 (UMLS CUI [3,2])
C1531518 (UMLS CUI [4,1])
C0205420 (UMLS CUI [4,2])
C0279025 (UMLS CUI [5,1])
C0205420 (UMLS CUI [5,2])
Meningeal Carcinomatosis
Item
Subjects with evidence of leptomeningeal carcinomatosis at screening.
boolean
C0220654 (UMLS CUI [1])
Lapatinib, Hypersensitivity
Item
History of allergic reactions attributed to compounds of similar chemical composition (quinazolines) to lapatinib.
boolean
C1506770 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
Capecitabine, Hypersensitivity; Fluorouracil allergy
Item
History of allergic reactions attributed to compounds chemically related to capecitabine, fluorouracil or any excipients.
boolean
C0671970 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0570698 (UMLS CUI [2])
Combined Modality Therapy
Item
Concurrent treatment with medications listed in Section 7.2 and Section 13.6, Prohibited Medications.
boolean
C0009429 (UMLS CUI [1])
Malabsorption Syndrome; Disease, Affecting, gastrointestinal function
Item
Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel. Subjects with active, uncontrolled ulcerative colitis are also excluded
boolean
C0024523 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0516983 (UMLS CUI [2,3])
Gadolinium-based Contrast Agent [EPC], Hypersensitivity; Gadolinium-based Contrast Agent [EPC], Medical contraindication
Item
History of immediate or delayed hypersensitivity reaction to gadolinium contrast agents, or other contraindication to gadolinium contrast.
boolean
C3249258 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C3249258 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
Medical Resonance Imaging, Medical contraindication
Item
Other known contraindication to MRI, such as a cardiac pacemaker, implanted cardiac defibrillator, brain aneurysm clips, cochlear implant, ocular foreign body, or shrapnel.
boolean
C0024485 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
Comorbidity
Item
Concurrent disease or condition that would make the subject inappropriate for study participation or any serious medical or psychiatric disorder that would interfere with the subject's safety.
boolean
C0009488 (UMLS CUI [1])
Anticoagulant therapy
Item
Anticoagulant therapy at study entry (other than coumadin or aspirin as catheter prophylaxis, or a low dose heparin [i.e. 50 unit unfractionated] flush of a central venous device).
boolean
C0150457 (UMLS CUI [1])
Dementia; Abnormal mental state; Mental disorders
Item
Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent, unless a legally acceptable representative could provide informed consent (if in accord with the policies of the local Ethics Committee).
boolean
C0497327 (UMLS CUI [1])
C0278061 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
Cerebrovascular Disorders
Item
Pre-existing severe cerebral vascular disease, such as stroke involving a major vessel, CNS vasculitis, or malignant hypertension.
boolean
C0007820 (UMLS CUI [1])
Heart Diseases, Active
Item
Active cardiac disease, defined as one or more of the following: • History of uncontrolled or symptomatic angina • History of arrhythmias requiring medications, or clinically significant • Myocardial infarction < 6 months from study entry • Uncontrolled or symptomatic congestive heart failure • Ejection fraction below the institutional normal limit • Any other cardiac condition, which in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient.
boolean
C0018799 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
Communicable Diseases, Uncontrolled
Item
Uncontrolled infection.
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy; Breastfeeding
Item
Pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Malignant Neoplasms, Other
Item
History of other malignancy, except for curatively treated basal cell carcinoma or squamous cell carcinoma of the skin, or carcinoma in situ of the cervix. Subjects with other malignancies who have been disease-free for at least 5 years are eligible.
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Liver diseases, Active; Biliary Tract Diseases, Active
Item
Have current active hepatic or biliary disease (with exception of subjects with Gilbert's syndrome, asymptomatic gallstones, liver metastases or stable chronic liver disease per investigator assessment).
boolean
C0023895 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0005424 (UMLS CUI [2,1])
C0205177 (UMLS CUI [2,2])
Laboratory Procedures, Chemistry, Clinical, Laboratory Identifier
Item
Laboratory ID
integer
C0022885 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C2986056 (UMLS CUI [1,3])
Item
Laboratory Used For This Sample
text
C0022885 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0022877 (UMLS CUI [1,3])
Code List
Laboratory Used For This Sample
Laboratory Procedures, Chemistry, Clinical, Sampling, Date in time
Item
Date sample taken
date
C0022885 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
ALT
text
C0022885 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Item
ALT - Results
text
C0022885 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Alanine aminotransferase measurement, Result, Unit of Measure
Item
ALT - Units
text
C0022885 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Alanine aminotransferase measurement, Result, Lower limit of reference range
Item
ALT - Low
text
C0022885 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Alanine aminotransferase measurement, Result, Upper Limit of Normal
Item
ALT - High
text
C0022885 (UMLS CUI [1,1])
C0201836 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
AST
text
C0022885 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
Item
AST - Results
text
C0022885 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Aspartate aminotransferase measurement, Result, Unit of Measure
Item
AST - Units
text
C0022885 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Item
AST - Low
text
C0022885 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Aspartate aminotransferase measurement, Result, Upper Limit of Normal
Item
AST - High
text
C0022885 (UMLS CUI [1,1])
C0201899 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Total Bilirubin
text
C0022885 (UMLS CUI [1,1])
C0201913 (UMLS CUI [1,2])
Code List
Total Bilirubin
Laboratory Procedures, Bilirubin, total measurement, Result
Item
Total Bilirubin - Results
text
C0022885 (UMLS CUI [1,1])
C0201913 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Bilirubin, total measurement, Result, Unit of Measure
Item
Total Bilirubin - Units
text
C0022885 (UMLS CUI [1,1])
C0201913 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Bilirubin, total measurement, Result, Lower limit of reference range
Item
Total Bilirubin - Low
text
C0022885 (UMLS CUI [1,1])
C0201913 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Bilirubin, total measurement, Result, Upper Limit of Normal
Item
Total Bilirubin - High
text
C0022885 (UMLS CUI [1,1])
C0201913 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Glucose
text
C0022885 (UMLS CUI [1,1])
C0337438 (UMLS CUI [1,2])
Laboratory Procedures, Glucose measurement, Result
Item
Glucose - Results
text
C0022885 (UMLS CUI [1,1])
C0337438 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Glucose measurement, Result, Unit of Measure
Item
Glucose - Units
text
C0022885 (UMLS CUI [1,1])
C0337438 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Glucose measurement, Result, Upper Limit of Normal
Item
Glucose - High
text
C0022885 (UMLS CUI [1,1])
C0337438 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Total Protein
text
C0022885 (UMLS CUI [1,1])
C0555903 (UMLS CUI [1,2])
Laboratory Procedures, Total protein measurement, Result, Unit of Measure
Item
Total Protein - Units
text
C0022885 (UMLS CUI [1,1])
C0555903 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Total protein measurement, Result, Lower limit of reference range
Item
Total Protein - Low
text
C0022885 (UMLS CUI [1,1])
C0555903 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Total protein measurement, Result, Upper Limit of Normal
Item
Total Protein - High
text
C0022885 (UMLS CUI [1,1])
C0555903 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Potassium
text
C0022885 (UMLS CUI [1,1])
C0202194 (UMLS CUI [1,2])
Laboratory Procedures, Potassium measurement, Result
Item
Potassium - Results
text
C0022885 (UMLS CUI [1,1])
C0202194 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Potassium measurement, Result, Unit of Measure
Item
Potassium - Units
text
C0022885 (UMLS CUI [1,1])
C0202194 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Potassium measurement, Result, Lower limit of reference range
Item
Potassium - Low
text
C0022885 (UMLS CUI [1,1])
C0202194 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Potassium measurement, Result, Upper Limit of Reference Range
Item
Potassium - High
text
C0022885 (UMLS CUI [1,1])
C0202194 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Sodium
text
C0022885 (UMLS CUI [1,1])
C0337443 (UMLS CUI [1,2])
Item
Sodium - Results
text
C0022885 (UMLS CUI [1,1])
C0337443 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Sodium - Results
Laboratory Procedures, Sodium measurement, Result, Unit of Measure
Item
Sodium - Units
text
C0022885 (UMLS CUI [1,1])
C0337443 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Sodium measurement, Result, Lower limit of reference range
Item
Sodium - Low
text
C0022885 (UMLS CUI [1,1])
C0337443 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Sodium measurement, Result, Upper Limit of Normal
Item
Sodium - High
text
C0022885 (UMLS CUI [1,1])
C0337443 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Calcium
text
C0022885 (UMLS CUI [1,1])
C0201925 (UMLS CUI [1,2])
Laboratory Procedures, Calcium measurement, Result
Item
Calcium - Results
text
C0022885 (UMLS CUI [1,1])
C0201925 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Calcium measurement, Result, Unit of Measure
Item
Calcium - Units
text
C0022885 (UMLS CUI [1,1])
C0201925 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Calcium measurement, Result, Lower limit of reference range
Item
Calcium - Low
text
C0022885 (UMLS CUI [1,1])
C0201925 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Calcium measurement, Result, Upper Limit of Normal
Item
Calcium - High
text
C0022885 (UMLS CUI [1,1])
C0201925 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Alkaline Phosphatase
text
C0022885 (UMLS CUI [1,1])
C0201850 (UMLS CUI [1,2])
Code List
Alkaline Phosphatase
Item
Alkaline Phosphatase - Results
text
C0022885 (UMLS CUI [1,1])
C0201850 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Alkaline Phosphatase - Results
Laboratory Procedures, Alkaline phosphatase measurement, Result, Unit of Measure
Item
Alkaline Phosphatase - Units
text
C0022885 (UMLS CUI [1,1])
C0201850 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Alkaline phosphatase measurement, Result, Lower limit of reference range
Item
Alkaline Phosphatase - Low
text
C0022885 (UMLS CUI [1,1])
C0201850 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Alkaline phosphatase measurement, Result, Upper Limit of Normal
Item
Alkaline Phosphatase - High
text
C0022885 (UMLS CUI [1,1])
C0201850 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
BUN
text
C0022885 (UMLS CUI [1,1])
C0005845 (UMLS CUI [1,2])
Item
BUN - Results
text
C0022885 (UMLS CUI [1,1])
C0005845 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Blood urea nitrogen measurement, Result, Upper Limit of Normal
Item
BUN - High
text
C0022885 (UMLS CUI [1,1])
C0005845 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Urea
text
C0022885 (UMLS CUI [1,1])
C0523961 (UMLS CUI [1,2])
Item
Urea - Results
text
C0022885 (UMLS CUI [1,1])
C0523961 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Urea measurement, Result, Unit of Measure
Item
Urea - Units
text
C0022885 (UMLS CUI [1,1])
C0523961 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Urea measurement, Result, Lower limit of reference range
Item
Urea - Low
text
C0022885 (UMLS CUI [1,1])
C0523961 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Urea measurement, Result, Upper Limit of Normal
Item
Urea - High
text
C0022885 (UMLS CUI [1,1])
C0523961 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Albumin
text
C0022885 (UMLS CUI [1,1])
C0201838 (UMLS CUI [1,2])
Laboratory Procedures, Albumin measurement, Result
Item
Albumin - Results
text
C0022885 (UMLS CUI [1,1])
C0201838 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Albumin measurement, Result, Unit of Measure
Item
Albumin - Units
text
C0022885 (UMLS CUI [1,1])
C0201838 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Albumin measurement, Result, Lower limit of reference range
Item
Albumin - Low
text
C0022885 (UMLS CUI [1,1])
C0201838 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Albumin measurement, Result, Upper Limit of Normal
Item
Albumin - High
text
C0022885 (UMLS CUI [1,1])
C0201838 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Creatinine
text
C0022885 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
Laboratory Procedures, Creatinine measurement, serum, Result
Item
Creatinine - Results
text
C0022885 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Creatinine measurement, serum, Result, Unit of Measure
Item
Creatinine - Units
text
C0022885 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Creatinine measurement, serum, Result, Lower limit of reference range
Item
Creatinine - Low
text
C0022885 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Laboratory Procedures, Creatinine measurement, serum, Result, Upper Limit of Normal
Item
Creatinine - High
text
C0022885 (UMLS CUI [1,1])
C0201976 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Item
Creatinine Clearance
text
C0022885 (UMLS CUI [1,1])
C0373595 (UMLS CUI [1,2])
Code List
Creatinine Clearance
Laboratory Procedures, Creatinine clearance measurement, Result
Item
Creatinine Clearance - Results
text
C0022885 (UMLS CUI [1,1])
C0373595 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Item
Creatinine Clearance - Units
text
C0022885 (UMLS CUI [1,1])
C0373595 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Code List
Creatinine Clearance - Units
Laboratory Procedures, Creatinine clearance measurement, Result, Lower limit of reference range
Item
Creatinine Clearance - Low
text
C0022885 (UMLS CUI [1,1])
C0373595 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Creatinine Clearance - High
text
C0022885 (UMLS CUI [1,1])
C0373595 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519815 (UMLS CUI [1,4])
Code List
Creatinine Clearance - High
Laboratory Procedures, Hematology finding, Laboratory Identifier
Item
Laboratory ID
integer
C0022885 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C2986056 (UMLS CUI [1,3])
Item
Laboratory Used For This Sample
text
C0022885 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C0022877 (UMLS CUI [1,3])
Code List
Laboratory Used For This Sample
Laboratory Procedures, Hematology finding, Sampling, Date in time
Item
Date sample taken
date
C0022885 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
WBC
text
C0022885 (UMLS CUI [1,1])
C0023508 (UMLS CUI [1,2])
Laboratory Procedures, White Blood Cell Count procedure, Result
Item
WBC - Results
text
C0022885 (UMLS CUI [1,1])
C0023508 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, White Blood Cell Count procedure, Result, Unit of Measure
Item
WBC - Units
text
C0022885 (UMLS CUI [1,1])
C0023508 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, White Blood Cell Count procedure, Result, Lower limit of reference range
Item
WBC - Low
text
C0022885 (UMLS CUI [1,1])
C0023508 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
RBC
text
C0022885 (UMLS CUI [1,1])
C0014772 (UMLS CUI [1,2])
Item
RBC - Results
text
C0022885 (UMLS CUI [1,1])
C0014772 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Red Blood Cell Count measurement, Result, Unit of Measure
Item
RBC - Units
text
C0022885 (UMLS CUI [1,1])
C0014772 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Red Blood Cell Count measurement, Result, Lower limit of reference range
Item
RBC - Low
text
C0022885 (UMLS CUI [1,1])
C0014772 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Haemoglobin
text
C0022885 (UMLS CUI [1,1])
C0019046 (UMLS CUI [1,2])
Laboratory Procedures, Hemoglobin, Result
Item
Haemoglobin - Results
text
C0022885 (UMLS CUI [1,1])
C0019046 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Hemoglobin, Result, Unit of Measure
Item
Haemoglobin - Units
text
C0022885 (UMLS CUI [1,1])
C0019046 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Hemoglobin, Result, Lower limit of reference range
Item
Haemoglobin - Low
text
C0022885 (UMLS CUI [1,1])
C0019046 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Haematocrit
text
C0022885 (UMLS CUI [1,1])
C0518014 (UMLS CUI [1,2])
Laboratory Procedures, Hemoglobin level, Result
Item
Haematocrit - Results
text
C0022885 (UMLS CUI [1,1])
C0518014 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Hemoglobin level, Result, Unit of Measure
Item
Haematocrit - Units
text
C0022885 (UMLS CUI [1,1])
C0518014 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Hemoglobin level, Result, Lower limit of reference range
Item
Haematocrit - Low
text
C0022885 (UMLS CUI [1,1])
C0518014 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Lymphocytes
text
C0022885 (UMLS CUI [1,1])
C0024264 (UMLS CUI [1,2])
Laboratory Procedures, Lymphocyte, Result
Item
Lymphocytes - Results
text
C0022885 (UMLS CUI [1,1])
C0024264 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Lymphocyte, Result, Unit of Measure
Item
Lymphocytes - Units
text
C0022885 (UMLS CUI [1,1])
C0024264 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Lymphocyte, Result, Lower limit of reference range
Item
Lymphocytes - Low
text
C0022885 (UMLS CUI [1,1])
C0024264 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Units for Lymphocytes
text
C0022885 (UMLS CUI [1,1])
C0024264 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])
Code List
Units for Lymphocytes
CL Item
Absolute count (2)
Item
Monocytes
text
C0022885 (UMLS CUI [1,1])
C0026473 (UMLS CUI [1,2])
Item
Monocytes - Results
text
C0022885 (UMLS CUI [1,1])
C0026473 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Monocytes - Results
Laboratory Procedures, Monocytes, Result, Unit of Measure
Item
Monocytes - Units
text
C0022885 (UMLS CUI [1,1])
C0026473 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Monocytes, Result, Lower limit of reference range
Item
Monocytes - Low
text
C0022885 (UMLS CUI [1,1])
C0026473 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Units for Monocytes
text
C0022885 (UMLS CUI [1,1])
C0026473 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])
Code List
Units for Monocytes
CL Item
Absolute count (2)
Item
Eosinophils
text
C0022885 (UMLS CUI [1,1])
C0200638 (UMLS CUI [1,2])
Laboratory Procedures, Eosinophil count procedure, Result
Item
Eosinophils - Results
text
C0022885 (UMLS CUI [1,1])
C0200638 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Laboratory Procedures, Eosinophil count procedure, Result, Unit of Measure
Item
Eosinophils - Units
text
C0022885 (UMLS CUI [1,1])
C0200638 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Eosinophil count procedure, Result, Lower limit of reference range
Item
Eosinophils - Low
text
C0022885 (UMLS CUI [1,1])
C0200638 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Unit of Eosinophils
text
C0022885 (UMLS CUI [1,1])
C0200638 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])
Code List
Unit of Eosinophils
CL Item
Absolute count (2)
Item
Basophils
text
C0022885 (UMLS CUI [1,1])
C0200641 (UMLS CUI [1,2])
Item
Basophils - Results
text
C0022885 (UMLS CUI [1,1])
C0200641 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Basophils - Results
Laboratory Procedures, Blood basophil count (lab test), Result, Unit of Measure
Item
Basophils - Units
text
C0022885 (UMLS CUI [1,1])
C0200641 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1519795 (UMLS CUI [1,4])
Laboratory Procedures, Blood basophil count (lab test), Result, Lower limit of reference range
Item
Basophils - Low
text
C0022885 (UMLS CUI [1,1])
C0200641 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C1272773 (UMLS CUI [1,4])
Item
Basophils - Units
text
C0022885 (UMLS CUI [1,1])
C0200641 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])
Code List
Basophils - Units
CL Item
Absolute count (2)
Item
Platelets
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
Item
Platelets - Results
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Platelets - Results
Item
Platelets - Results
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Platelets - Results
Item
Platelets - Results
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Platelets - Results
Item
Platelets - Results
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
Code List
Platelets - Results
Item
Platelets
text
C0022885 (UMLS CUI [1,1])
C0032181 (UMLS CUI [1,2])
Central Laboratory, Hematology finding, Sampling, Date in time
Item
Hematology Date sample taken
date
C1880016 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Central Laboratory, Hematology finding, Sampling, Not Done
Item
Not Done
boolean
C1880016 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C1272696 (UMLS CUI [1,4])
Central Laboratory, Chemistry, Clinical, Sampling, Date in time
Item
Clinical Chemistry Date sample taken
date
C1880016 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Central Laboratory, Chemistry, Clinical, Sampling, Not Done
Item
Not Done
boolean
C1880016 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,3])
C1272696 (UMLS CUI [1,4])
Central Laboratory, Hematology finding, Laboratory, Code
Item
Haem Lab type code
text
C1880016 (UMLS CUI [1,1])
C0474523 (UMLS CUI [1,2])
C0022877 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
Central Laboratory, Chemistry, Clinical, Laboratory, Code
Item
Chem Lab type code
text
C1880016 (UMLS CUI [1,1])
C0008000 (UMLS CUI [1,2])
C0022877 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
Cancer treatment, Prior Therapy
Item
Sequence Number
integer
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,3])
Cancer treatment, Prior Therapy, Medication name
Item
Drug Name
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
Cancer treatment, Prior Therapy, Reported Term
Item
Modified reported term
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C2826302 (UMLS CUI [1,3])
Cancer treatment, Prior Therapy, Synonym
Item
GSK drug synonym
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0871468 (UMLS CUI [1,3])
Cancer treatment, Prior Therapy, Collection, Code
Item
GSK Drug Collection code
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,3])
C0805701 (UMLS CUI [1,4])
Cancer treatment, Prior Therapy, Code, Failed
Item
Failed coding
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
Cancer treatment, Prior Therapy, Chemotherapy Regimen, Sequence Number
Item
Regimen Sequence
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C2348184 (UMLS CUI [1,4])
Item
Therapy Type
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
CL Item
Biologic Therapy (antibodies, cytokines) (1)
CL Item
Chemotherapy (cytotoxics, non-cytotoxics) (2)
CL Item
Hormonal Therapy (3)
CL Item
Immunotherapy (4)
Item
Cumulative Dose for Anthracyclines
integer
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0282564 (UMLS CUI [1,3])
C2986497 (UMLS CUI [1,4])
Code List
Cumulative Dose for Anthracyclines
Item
Intent
text
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1283828 (UMLS CUI [1,3])
CL Item
Advanced or Metastatic (3)
CL Item
Local/Regional (4)
CL Item
Not Applicable (5)
Cancer treatment, Prior Therapy, Start Date
Item
Start Date
date
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Cancer treatment, Prior Therapy, End date
Item
Stop Date
date
C0920425 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
Item
Level of consciousness
text
C0234425 (UMLS CUI [1])
Code List
Level of consciousness
CL Item
Somnolence or sedation not interfering with function (2)
CL Item
Somnolence or sedation interfering with function, but not interfering with Activities of Daily Living (ADLs) (3)
CL Item
Obtundation or stupor; difficult to arouse; interfering with ADLs (4)
Item
Neurological symptoms
text
C0235031 (UMLS CUI [1])
Code List
Neurological symptoms
CL Item
No - Asymptomatic (1)
CL Item
Headache - Grade 1 (2)
CL Item
Headache - Grade 2 (3)
CL Item
Headache - Grade 3 (4)
CL Item
Headache - Grade 4 (5)
CL Item
Dizziness/lightheadedness - Grade 1 (6)
CL Item
Dizziness/lightheadedness - Grade 2 (7)
CL Item
Dizziness/lightheadedness - Grade 3 (8)
CL Item
Dizziness/lightheadedness - Grade 4 (9)
CL Item
Vertigo - Grade 1 (10)
CL Item
Vertigo - Grade 2 (11)
CL Item
Vertigo - Grade 3 (12)
CL Item
Vertigo - Grade 4 (13)
CL Item
Nausea/vomiting - Grade 1 (14)
CL Item
Nausea/vomiting - Grade 2 (15)
CL Item
Nausea/vomiting - Grade 3 (16)
CL Item
Nausea/vomiting - Grade 4 (17)
CL Item
Visual problems - Grade 1 (18)
CL Item
Visual problems - Grade 2 (19)
CL Item
Visual problems - Grade 3 (20)
CL Item
Visual problems - Grade 4 (21)
CL Item
Seizure - Grade 1 (22)
CL Item
Seizure - Grade 2 (23)
CL Item
Seizure - Grade 3 (24)
CL Item
Seizure - Grade 4 (25)
CL Item
Other, specify other neurological symptom(s) in the Other Neurological Symptoms section (26)
Neurologic Symptoms, Other
Item
Other Neurological Symptoms - Specify neurological symptom
text
C0235031 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Item
Other Neurological Symptoms - CTCAE Grade
text
C0235031 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2985911 (UMLS CUI [1,3])
Code List
Other Neurological Symptoms - CTCAE Grade
Item
Cranial Nerves and Language - Cranial nerves II-XII
text
C0010268 (UMLS CUI [1])
Code List
Cranial Nerves and Language - Cranial nerves II-XII
CL Item
Present, not interfering w/ADLs (2)
CL Item
Present, interfering w/ADLs (3)
CL Item
Life-threatening, disabling (4)
Item
Cranial Nerves and Language - If abnormal, specify which nerve(s) affected
text
C0010268 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
Code List
Cranial Nerves and Language - If abnormal, specify which nerve(s) affected
Item
Cranial Nerves and Language - Language - Dysphasia or aphasia
text
C0973461 (UMLS CUI [1])
C0003537 (UMLS CUI [2])
Code List
Cranial Nerves and Language - Language - Dysphasia or aphasia
CL Item
Awareness of receptive or expressive aphasia, not impairing ability to communicate (2)
CL Item
Receptive or expressive dysphasia, impairing ability to communicate (3)
CL Item
Inability to communicate (4)
Item
Strength - Right upper extremity
text
C0517349 (UMLS CUI [1,1])
C0230329 (UMLS CUI [1,2])
Code List
Strength - Right upper extremity
Item
Strength - Right upper extremity - If abnormal, specify the muscle group
text
C0517349 (UMLS CUI [1,1])
C0230329 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0026845 (UMLS CUI [1,4])
Code List
Strength - Right upper extremity - If abnormal, specify the muscle group
Item
Strength - Right upper extremity - Grade
text
C0517349 (UMLS CUI [1,1])
C0230329 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0441800 (UMLS CUI [1,4])
Code List
Strength - Right upper extremity - Grade
CL Item
Grade 1 - asymptomatic with weakness on physical exam (1)
CL Item
Grade 2 - symptomatic and interfering w/function, but not interfering with ADLs (2)
CL Item
Grade 3 - symptomatic and interfering with activities of daily living (3)
CL Item
Grade 4 - bedridden or disabling (4)
Item
Strength - Left upper extremity
text
C0517349 (UMLS CUI [1,1])
C0230330 (UMLS CUI [1,2])
Code List
Strength - Left upper extremity
Muscle Strength, Left upper extremity, Abnormality, Muscle
Item
Strength - Left upper extremity - If abnormal, specify the muscle group
text
C0517349 (UMLS CUI [1,1])
C0230330 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0026845 (UMLS CUI [1,4])
Item
Strength - Left upper extremity - Grade
text
C0517349 (UMLS CUI [1,1])
C0230330 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0441800 (UMLS CUI [1,4])
Code List
Strength - Left upper extremity - Grade
CL Item
Grade 1 - asymptomatic with weakness on physical exam (1)
CL Item
Grade 2 - symptomatic and interfering w/function, but not interfering with ADLs (2)
CL Item
Grade 3 - symptomatic and interfering with activities of daily living (3)
CL Item
Grade 4 - bedridden or disabling (4)
Item
Strength - Right lower extremity
text
C0517349 (UMLS CUI [1,1])
C0230415 (UMLS CUI [1,2])
Code List
Strength - Right lower extremity
Muscle Strength, Right lower extremity, Abnormality, Muscle
Item
Strength - Right lower extremity - If abnormal, specify the muscle group
text
C0517349 (UMLS CUI [1,1])
C0230415 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0026845 (UMLS CUI [1,4])
Item
Strength - Right lower extremity - Grade
text
C0517349 (UMLS CUI [1,1])
C0230415 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0441800 (UMLS CUI [1,4])
Code List
Strength - Right lower extremity - Grade
CL Item
Grade 1 - asymptomatic with weakness on physical exam (1)
CL Item
Grade 2 - symptomatic and interfering w/function, but not interfering with ADLs (2)
CL Item
Grade 3 - symptomatic and interfering with activities of daily living (3)
CL Item
Grade 4 - bedridden or disabling (4)
Item
Strength - Left lower extremity
text
C0517349 (UMLS CUI [1,1])
C0230416 (UMLS CUI [1,2])
Code List
Strength - Left lower extremity
Muscle Strength, Left lower extremity, Abnormality, Muscle
Item
Strength - Left lower extremity - If abnormal, specify the muscle group
text
C0517349 (UMLS CUI [1,1])
C0230416 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0026845 (UMLS CUI [1,4])
Item
Strength - Left lower extremity - Grade
text
C0517349 (UMLS CUI [1,1])
C0230416 (UMLS CUI [1,2])
C1704258 (UMLS CUI [1,3])
C0441800 (UMLS CUI [1,4])
Code List
Strength - Left lower extremity - Grade
CL Item
Grade 1 - asymptomatic with weakness on physical exam (1)
CL Item
Grade 2 - symptomatic and interfering w/function, but not interfering with ADLs (2)
CL Item
Grade 3 - symptomatic and interfering with activities of daily living (3)
CL Item
Grade 4 - bedridden or disabling (4)
Item
Sensation
text
C0036658 (UMLS CUI [1])
CL Item
Loss of deep tendon reflexes or paresthesia, but not interfering with function (2)
CL Item
Objective sensory loss or paresthesia interfering with function, but no interfering with ADLs (3)
CL Item
Sensory loss or paresthesia interfering with ADLs (4)
CL Item
Permanent sensory loss that interferes with function (5)
Item
Sensation - If abnormal, specify location/distribution
text
C0036658 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
Code List
Sensation - If abnormal, specify location/distribution
Item
Ataxia - Right upper extremity (finger to nose testing)
text
C0004134 (UMLS CUI [1,1])
C0230329 (UMLS CUI [1,2])
Code List
Ataxia - Right upper extremity (finger to nose testing)
CL Item
Abnormal - Grade 1 - asymptomatic but abnormal on physical exam, and not interfering with function (2)
CL Item
Abnormal - Grade 2 - mild symptoms interfering with function, but not interfering with activities of daily living (3)
CL Item
Abnormal - Grade 3 - moderate symptoms interfering with activities of daily living (4)
CL Item
Abnormal - Grade 4 - bedridden or disabling (5)
Item
Ataxia - Left upper extremity (finger to nose testing)
text
C0004134 (UMLS CUI [1,1])
C0230330 (UMLS CUI [1,2])
Code List
Ataxia - Left upper extremity (finger to nose testing)
CL Item
Abnormal - Grade 1 - asymptomatic but abnormal on physical exam, and not interfering with function (2)
CL Item
Abnormal - Grade 2 - mild symptoms interfering with function, but not interfering with activities of daily living (3)
CL Item
Abnormal - Grade 3 - moderate symptoms interfering with activities of daily living (4)
CL Item
Abnormal - Grade 4 - bedridden or disabling (5)
Item
Ataxia - Gait
text
C0751837 (UMLS CUI [1])
CL Item
Abnormal - Grade 1 - asymptomatic but abnormal on physical exam, and not interfering with function (2)
CL Item
Abnormal - Grade 2 - mild symptoms interfering with function, but not interfering with activities of daily living (3)
CL Item
Abnormal - Grade 3 - moderate symptoms interfering with activities of daily living (4)
CL Item
Abnormal - Grade 4 - bedridden or disabling (5)
Item
Ataxia - Balance (Romberg)
text
C0004134 (UMLS CUI [1,1])
C0560184 (UMLS CUI [1,2])
Code List
Ataxia - Balance (Romberg)
CL Item
Abnormal - Grade 1 - asymptomatic but abnormal on physical exam, and not interfering with function (2)
CL Item
Abnormal - Grade 2 - mild symptoms interfering with function, but not interfering with activities of daily living (3)
CL Item
Abnormal - Grade 3 - moderate symptoms interfering with activities of daily living (4)
CL Item
Abnormal - Grade 4 - bedridden or disabling (5)